Ortin Global Limited (BOM:539287)

Market Cap	125.06M
Revenue (ttm)	1.74M
Net Income (ttm)	-9.49M
Shares Out	8.13M
EPS (ttm)	-1.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,108
Average Volume	4,433
Open	15.38
Previous Close	13.99
Day's Range	15.00 - 15.38
52-Week Range	9.57 - 22.88
Beta	0.41
RSI	74.86
Earnings Date	Nov 14, 2025

About Ortin Global

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulceran...

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Employees: 3
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539287

Financial Performance

In 2024, Ortin Global's revenue was 3.43 million, a decrease of -84.61% compared to the previous year's 22.26 million. Losses were -8.46 million, -89.47% less than in 2023.